Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Tobias

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurology|June 11, 2008
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyDavid M Simpson, Stephen Brown, Jeffrey Tobias, et al.
Hematological Oncology|June 16, 2015
17P deleted multiple myeloma presenting with intracranial disease: durable remission after tailored managementJoe Lee, Dean Smith, Neil Rabin, et al.
The Lancet. Neurology|November 4, 2008
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyMiroslav Backonja, Mark S Wallace, E Richard Blonsky, et al.
Pain Medicine (Malden, Mass.)|November 20, 2010
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaGordon A Irving, Miroslav M Backonja, Edwin Dunteman, et al.
The Journal of Pain|April 20, 2010
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteersWilliam R Kennedy, Geertrui F Vanhove, Shiao-Ping Lu, et al.
JAMA|July 10, 2003
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trialEdward Abraham, Konrad Reinhart, Steven Opal, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 7, 2016
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendationsRobert R Edwards, Robert H Dworkin, Dennis C Turk, et al.
Pain|June 11, 2020
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurology|June 11, 2008
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyDavid M Simpson, Stephen Brown, Jeffrey Tobias, et al.
Hematological Oncology|June 16, 2015
17P deleted multiple myeloma presenting with intracranial disease: durable remission after tailored managementJoe Lee, Dean Smith, Neil Rabin, et al.
The Lancet. Neurology|November 4, 2008
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyMiroslav Backonja, Mark S Wallace, E Richard Blonsky, et al.
Pain Medicine (Malden, Mass.)|November 20, 2010
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaGordon A Irving, Miroslav M Backonja, Edwin Dunteman, et al.
The Journal of Pain|April 20, 2010
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteersWilliam R Kennedy, Geertrui F Vanhove, Shiao-Ping Lu, et al.
JAMA|July 10, 2003
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trialEdward Abraham, Konrad Reinhart, Steven Opal, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 7, 2016
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendationsRobert R Edwards, Robert H Dworkin, Dennis C Turk, et al.
Pain|June 11, 2020
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pageof 2